ABC
AMPH icon

Associated Banc-Corp’s Amphastar Pharmaceuticals AMPH Stock Holding History

Associated Banc-Corp’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-85
Closed -$2K – 312
2020
Q4 		$2K Hold
85
– – ﹤0.01% 730
2020
Q3 		$2K Hold
85
– – ﹤0.01% 623
2020
Q2 		$2K Buy
+85
New +$1.56K ﹤0.01% 599

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Associated Banc-Corp's AMPH Position: Q1 2021 in Review

Associated Banc-Corp sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2021, closing a stake of 85 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in AMPH in Q2 2020 and held it in 3 quarters. The position peaked at $2K in Q4 2020. 135 funds tracked by Wall St. Rank hold AMPH as of Q1 2021.

  • Associated Banc-Corp reported no remaining Amphastar Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 85 Amphastar Pharmaceuticals shares in Q1 2021, an estimated $2K.
  • Associated Banc-Corp first reported a position in Amphastar Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Associated Banc-Corp's Amphastar Pharmaceuticals position peaked at $2K in Q4 2020.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.